Missed a Low-Dose GLP-1? Check the Product First

A missed low-dose GLP-1 injection does not have one universal catch-up rule. The medication, formulation, time since the missed dose and length of the interruption all matter. Wegovy injection and Zepbound have different label instructions; a compounded microdose needs instructions from the prescriber or dispensing pharmacist ^1,2,3.

Do not double the next dose to make up for a missed one or borrow someone else's restart schedule. If the instructions on your pharmacy label are unclear, the useful next step is to confirm the product and timing before taking another dose.

One late injection and a treatment break are different questions

Missing an injection by a day is different from returning after several weeks without treatment. A label may describe a window for a single missed dose while giving different directions for several consecutive missed doses. Reading only the first sentence can leave out the part that applies to you.

Start with a short record: the name of the medicine, the exact product, the date and time of the last dose actually taken, the scheduled date that was missed, and the next planned dose. Include any illness or side effects that led you to stop. A calendar entry is more useful than saying that you are "a little late."

If you cannot remember whether you already injected, do not treat uncertainty as proof that you missed it. Ask the pharmacist or prescriber how to proceed. A catch-up dose taken after an unrecorded injection would create a different problem.

Zepbound and Wegovy use different timing language

The Zepbound label describes a missed-dose window of four days, or 96 hours, after the scheduled dose. Beyond that window, it directs patients to skip the missed dose and return to the regular schedule. The same label has a separate minimum spacing rule when changing the weekly dosing day ¹.

Wegovy injection instead describes timing relative to the next scheduled dose. Its current prescribing information also addresses two or more consecutive missed injections, directing reinitiation of escalation at a lower dosage to reduce gastrointestinal reactions. A prescriber should determine how those instructions apply after a treatment break ².

This comparison explains why the product name matters. It is not a replacement calendar for someone using a custom compounded prescription. If you are at a timing boundary, taking another medicine, or unsure which presentation you have, ask for product-specific guidance.

Why a compounded microdose needs its own written instructions

A pharmacy vial can have a different concentration, container and measuring system from a branded pen. FDA has documented dosing mistakes involving confusion between milligrams, milliliters and syringe markings, including errors made by both patients and clinicians ³.

"Take the usual amount" is not enough if your usual amount was a syringe mark from an older vial. Before discussing a restart, check whether the medicine, concentration or syringe has changed. Have the actual label available for the call. If an old message and a new label disagree, ask the pharmacy to reconcile them rather than choosing the instruction that seems familiar.

Our compounded GLP-1 concentration guide explains the refill issue. A missed-dose conversation should resolve timing and product identity together; it should not leave you to convert a branded pen schedule into a vial volume yourself.

A longer gap is a reason to check tolerability again

A previous dose that felt manageable does not automatically become the right restart dose after an interruption. The reason for the gap matters too. Running out of medicine, recovering from surgery and stopping because of persistent vomiting are different situations.

Tell the clinician what happened before you stopped and what has changed since. Include new medicines, pregnancy plans, difficulty eating or drinking, and any symptoms that are still present. The question is not simply whether the old vial contains enough medicine. It is whether the treatment plan still fits your circumstances.

For the separate problem of reducing or stopping treatment intentionally, see tapering off a GLP-1. A planned taper and an accidental missed dose should not be treated as interchangeable.

Do not turn a late dose into split dosing

Some online advice suggests taking part of a dose now and the rest later. That changes the prescribed regimen rather than merely recording a missed dose. Do not improvise a split schedule or use a calculator to design one.

The same applies to taking extra medication because appetite has returned. Hunger is not a measurement of how much drug remains in your body, and it cannot identify a safe catch-up amount. Our split-dosing evidence guide discusses the separate evidence questions.

Make the next refill less confusing

Ask the provider for a written plan covering a single missed dose, a longer interruption and a refill with a different concentration. Save that plan beside the medication label, with a way to reach the dispensing pharmacy. Keep a record after each administration rather than relying on memory.

When comparing programs, ask who answers a missed-dose question outside routine appointment hours and how quickly a clinician can review a restart. A low advertised price does not tell you how these practical questions are handled. Our provider checklist covers the service details worth confirming before paying.

The safest useful answer is specific: the exact medicine, the actual dates, the current label and the prescriber's instructions. A general "microdose" label does not supply those details.